CN Patent

CN107021917B — 哌马色林半酒石酸盐的新晶型及其制备方法

Assigned to Shanghai Shujing Biotechnology Co ltd · Expires 2020-08-04 · 6y expired

What this patent protects

本发明涉及式(I)所示哌马色林半酒石酸盐的晶型II和无定型、其制备方法。本发明的哌马色林半酒石酸盐晶型II和无定型具有良好的稳定性和更好的溶解性能。

USPTO Abstract

本发明涉及式(I)所示哌马色林半酒石酸盐的晶型II和无定型、其制备方法。本发明的哌马色林半酒石酸盐晶型II和无定型具有良好的稳定性和更好的溶解性能。

Drugs covered by this patent

pimavanserin-tartrate (PIMAVANSERIN TARTRATE)

Patent Metadata

Patent number: CN107021917B
Jurisdiction: CN
Classification: —
Expires: 2020-08-04
Drug substance claim: No
Drug product claim: No
Assignee: Shanghai Shujing Biotechnology Co ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.